Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia 40Lymphoma 39Melanoma 27Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Non-Hodgkin 24Lymphoma, Follicular 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Breast Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Lymphoma, Mantle-Cell 19Myelodysplastic Syndromes 17Neuroblastoma 16Lymphoma, Large-Cell, Immunoblastic 16Hodgkin Disease 16Multiple Myeloma 15Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Acute 15Burkitt Lymphoma 15Lymphoma, B-Cell, Marginal Zone 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Prostatic Neoplasms 13Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Neoplasms, Plasma Cell 10Leukemia, Myeloid, Accelerated Phase 10Glioblastoma 10Congenital Abnormalities 10Carcinoma, Ovarian Epithelial 9Ovarian Neoplasms 8

Interventions

Methotrexate 21Ifosfamide 21Cyclophosphamide 19Doxorubicin 17Cisplatin 14Filgrastim 13Gemcitabine 12Etoposide 11Leucovorin 9apatinib 8fludarabine 7glucarpidase 6Vincristine 6Temozolomide 6Radiotherapy 6Nivolumab 6Neoadjuvant Therapy 6Drug Therapy 6Carboplatin 6regorafenib 5cabozantinib 5Zoledronic Acid 5Topotecan 5Mesna 5Irinotecan 5Granulocyte Colony-Stimulating Factor 5Docetaxel 5pembrolizumab 4pegfilgrastim 4camrelizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteosarcoma × sargramostim × Clear all
NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡